Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.
about
Cationic surface charge enhances early regional deposition of liposomes after intracarotid injectionLiposome size and charge optimization for intraarterial delivery to gliomas.Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronanCerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing rats.Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer ModelSystems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacyCytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor modelsAdvances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer.A robust and quantitative method for tracking liposome contents after intravenous administration.
P2860
Q30397446-191B83D3-86A7-4D9E-A4E4-CFDF7C85B923Q33901718-19DAF103-92D0-400C-B944-1882EA1377AFQ34145464-A0EC8B6F-B578-49B4-B2A1-B59EB2EA97C9Q34756425-FDDE57C3-C274-42FA-9C9A-4BE4A9964207Q36447756-AEACE730-769D-4957-B300-9BB06CEFCAC8Q36497582-BA715375-B4CB-4A7F-8D7E-796A3F8E6ED8Q37593608-F16AF916-04F6-48FB-838B-615B2071184DQ38808823-98C0C728-521A-4D0D-8D1A-74935293F54AQ40124132-ECFDC8C9-6EC2-4CCE-B9F3-A2E247CC64F2
P2860
Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.
@en
type
label
Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.
@en
prefLabel
Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.
@en
P2093
P2860
P1476
Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation
@en
P2093
Donald E Mager
Joseph A Spernyak
Richard Mazurchuk
Robert M Straubinger
Steven G Turowski
Tista Roy Chaudhuri
P2860
P304
P356
10.1007/S11095-012-0823-4
P577
2012-07-14T00:00:00Z